AAAAAA

   
Results: 1-7 |
Results: 7
TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/
Authors: CONNORS JM KLIMO P ADAMS G BURNS BF COOPER I MEYER RM OREILLY SE PATER J QUIRT I SADURA A SHUSTIK C SKILLINGS J SUTCLIFFE S VERMA S YOSHIDA S ZEE B
Citation: Jm. Connors et al., TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(4), 1997, pp. 1638-1645
MEDULLARY-THYROID CANCER - ANALYSES OF SURVIVAL AND PROGNOSTIC FACTORS AND THE ROLE OF RADIATION-THERAPY IN LOCAL-CONTROL
Authors: BRIERLEY J TSANG R SIMPSON WJ GOSPODAROWICZ M SUTCLIFFE S PANZARELLA T
Citation: J. Brierley et al., MEDULLARY-THYROID CANCER - ANALYSES OF SURVIVAL AND PROGNOSTIC FACTORS AND THE ROLE OF RADIATION-THERAPY IN LOCAL-CONTROL, Thyroid, 6(4), 1996, pp. 305-310
INTENSIVE THERAPY AND AUTOTRANSPLANT FOR PATIENTS WITH AN INCOMPLETE RESPONSE TO FRONT-LINE THERAPY FOR LYMPHOMA
Authors: PRINCE HM CRUMP M IMRIE K STEWART AK GIROUARD C BRANDWEIN JM CARSTAIRS K PANTALONY D SCOTT G SUTCLIFFE S SUTTON DMC TSANG R KEATING A
Citation: Hm. Prince et al., INTENSIVE THERAPY AND AUTOTRANSPLANT FOR PATIENTS WITH AN INCOMPLETE RESPONSE TO FRONT-LINE THERAPY FOR LYMPHOMA, Annals of oncology, 7(10), 1996, pp. 1043-1049
DICE (DEXAMETHASONE, IFOSFAMIDE, CISPLATIN, ETOPOSIDE) AS SALVAGE THERAPY IN NON-HODGKINS-LYMPHOMAS
Authors: GOSS P SHEPHERD F SCOTT JG BAKER M SUTTON D SUTCLIFFE S
Citation: P. Goss et al., DICE (DEXAMETHASONE, IFOSFAMIDE, CISPLATIN, ETOPOSIDE) AS SALVAGE THERAPY IN NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 18(1-2), 1995, pp. 123-129
HIGH-DOSE ETOPOSIDE, MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR ADVANCED HODGKINS-DISEASE - IMPORTANCE OF DISEASE STATUS ATTRANSPLANT
Authors: PRINCE HM CRUMP M IMRIE K STEWART AK BRANDEWEIN JM SUTTON DMC SCOTT JG SUTCLIFFE S TSANG R KEATING A
Citation: Hm. Prince et al., HIGH-DOSE ETOPOSIDE, MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR ADVANCED HODGKINS-DISEASE - IMPORTANCE OF DISEASE STATUS ATTRANSPLANT, Blood, 86(10), 1995, pp. 826-826
SECONDARY MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION IN ADULTS
Authors: LOWSKY R LIPTON J FYLES G MINDEN M MEHARCHAND J TEJPAR I ATKINS H SUTCLIFFE S MESSNER H
Citation: R. Lowsky et al., SECONDARY MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION IN ADULTS, Journal of clinical oncology, 12(10), 1994, pp. 2187-2192
PHARMACOLOGICAL MODULATION OF C-FOS MESSENGER-RNA EXPRESSION IN THE HL-60 AND U937 CELL-LINES
Authors: KOTECHA S WILSON L SUTCLIFFE S WANGOO A SHAW RJ
Citation: S. Kotecha et al., PHARMACOLOGICAL MODULATION OF C-FOS MESSENGER-RNA EXPRESSION IN THE HL-60 AND U937 CELL-LINES, Pulmonary pharmacology, 6(4), 1993, pp. 269-277
Risultati: 1-7 |